Expression of VEGF-C/VEGFR-3 and Its Clinical Significance in BTCC

ZU Xiongbing,YE Zhangqun,ZHOU Siwei,QI lin,SHEN Pengfei
DOI: https://doi.org/10.3969/j.issn.1001-1420.2006.01.008
2006-01-01
Journal of Clinical Urology
Abstract:Objective:The aim of this study was to determine VEGFR-3 in BTCC and its correlation with clinical findings and the expression of VEGF-C. The prognostic value of VEGF-C and VEGFR-3 related to progression of BTCC will be also evaluated.Methods:We assessed the levels of expression of VEGF-C and VEGFR-3 by RT-PCR and immunohistochemistry in 36 samples of BTCC and 8 normal bladder tissues.Results:VEGFR-3 was stained in tumor cells. Immunoreactivity for VEGFR-3 became significantly stronger with progressive lesions in tumor. The expression level of VEGFR-3 corresponded with that of VEGF-C in carcinoma cells. The expression levels of VEGF-C and VEGFR-3 in carcinoma cells were significantly corelated to lymphatic invasion.Conclusions:The present results suggest that an autocrine loop of VEGF-C via VEGFR-3 accelerates cells lymphatic invasion. Therefore, it will raise the possibility of anticarcinoma therapy which specifically targets VEGF-C/ VEGFR-3 interaction in BTCC.
What problem does this paper attempt to address?